1. Home
  2. BRAG vs VERU Comparison

BRAG vs VERU Comparison

Compare BRAG & VERU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Bragg Gaming Group Inc.

BRAG

Bragg Gaming Group Inc.

HOLD

Current Price

$1.16

Market Cap

38.8M

Sector

Technology

ML Signal

HOLD

Logo Veru Inc.

VERU

Veru Inc.

HOLD

Current Price

$2.29

Market Cap

41.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BRAG
VERU
Founded
2018
1971
Country
Canada
United States
Employees
N/A
N/A
Industry
Office Equipment/Supplies/Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
38.8M
41.9M
IPO Year
2021
1996

Fundamental Metrics

Financial Performance
Metric
BRAG
VERU
Price
$1.16
$2.29
Analyst Decision
Buy
Strong Buy
Analyst Count
2
3
Target Price
$4.30
★ $25.67
AVG Volume (30 Days)
10.1K
★ 206.4K
Earning Date
11-12-2026
08-10-2026
Dividend Yield
N/A
N/A
EPS Growth
★ N/A
N/A
EPS
★ N/A
N/A
Revenue
N/A
★ $16,296,958.00
Revenue This Year
N/A
N/A
Revenue Next Year
$5.62
N/A
P/E Ratio
N/A
★ N/A
Revenue Growth
★ N/A
N/A
52 Week Low
$1.11
$2.05
52 Week High
$2.80
$7.33

Technical Indicators

Market Signals
Indicator
BRAG
VERU
Relative Strength Index (RSI) 38.40 43.80
Support Level N/A $2.11
Resistance Level $1.82 $2.40
Average True Range (ATR) 0.06 0.15
MACD 0.01 -0.01
Stochastic Oscillator 9.55 28.13

Price Performance

Historical Comparison
BRAG
VERU

About BRAG Bragg Gaming Group Inc.

Bragg Gaming Group Inc is predominantly a B2B online gaming technology platform and casino content aggregator. The company's proprietary studios offer high-performing, data-driven casino gaming titles from in-house brands Wild Streak, Spin, Atomic Slot Lab, Indigo Magic, and Oryx Gaming. It offers a full range of games including slot games, table games, card games, video bingo, scratch card games, virtual sports, and live dealer games which are featured on the company's PAM platform and also available for use on other gaming platforms offered by third parties. Geographically, the company generates a majority of its revenue from Malta, and the rest from Netherlands, Curacao, the United States, Croatia, Marshall Islands, Brazil, Isle of Man, Belgium, Czech Republic, and other regions.

About VERU Veru Inc.

Veru Inc is a late clinical-stage biopharmaceutical focused on developing medicines for the treatment of cardiometabolic and inflammatory diseases. Its drug development program consists of two late-stage new chemical entities, enobosarm and sabizabulin. Enobosarm, an oral selective androgen receptor modulator, is being developed to make weight reduction by GLP-1 RA drugs more tissue selective for loss of fat and preservation of lean mass, and is planned for a Phase 2b PLATEAU clinical study in obesity. Sabizabulin, an oral microtubule disruptor, is being developed for the treatment of inflammation in atherosclerotic cardiovascular disease to lower high-sensitivity CRP in patients with stable coronary artery disease, with a planned Phase 2 study.

Share on Social Networks: